Related Experiment Videos
Geographical variations in all-cause mortality in Thailand
Patarapan Odton1, Chamnein Choonpradub, Kanitta Bundhamcharoen
1International Health Policy Program, Ministry of Public Health, Nonthaburi, Thailand.
The Southeast Asian Journal of Tropical Medicine and Public Health
|November 16, 2010
Summary
This study analyzed Thailand
Area of Science:
- Demography
- Public Health
- Epidemiology
Background:
- Mortality data from 1999-2001 in Thailand.
- Geographical variations in death rates require analysis.
Purpose of the Study:
- Examine age-specific death rates across Thai districts.
- Identify geographical patterns in mortality.
Main Methods:
- Used a Poisson generalized linear model for analysis.
- Reduced 926 districts to 235 "superdistricts" (min. 200,000 pop.) for population adjustment.
- Created thematic maps to visualize mortality rates relative to the mean.
Main Results:
- Northeastern Thailand showed higher than average mortality for both genders.
- Southern Thailand (except Phuket, Narathiwat) and Bangkok generally had lower death rates.
- Identified specific exceptions in Bangkok's superdistricts for females.
Conclusions:
- The modeling and mapping approach effectively highlights statistically valid geographical mortality variations.
- This method aids public health planners in developing targeted interventions.
- Understanding regional mortality differences is crucial for public health strategies.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Bias in Epidemiological Studies
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
01:52Regression Toward the Mean
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
01:22Applications of Life Tables
Life tables are versatile across various fields, providing a quantitative basis for analyzing mortality and survival rates. Whether used by demographers, actuaries, epidemiologists, or sociologists, life tables offer valuable insights into the dynamics of life and death, facilitating informed decisions in public health, insurance, conservation, and beyond. Their broad applicability highlights the interconnectedness of demographic data with practical outcomes in everyday life and strategic...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...